<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Eflornithine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Eflornithine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mediawiki.page.gallery.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.page.gallery.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Eflornithine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Eflornithine</b>, sold under the brand name <b>Vaniqa</b> among others, is a medication used to treat African trypanosomiasis (sleeping sickness) and excessive hair growth on the face in women.<span class="mw-ref" id="cite_ref-WHO2015E_1-0"><a href="#cite_note-WHO2015E-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2016_2-0"><a href="#cite_note-AHFS2016-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Specifically it is used for the 2nd stage of sleeping sickness caused by <i>T. b. gambiense</i> and may be used with nifurtimox.<span class="mw-ref" id="cite_ref-WHO2015E_1-1"><a href="#cite_note-WHO2015E-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-CDC2016_3-0"><a href="#cite_note-CDC2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is used by injection or applied to the skin.<span class="mw-ref" id="cite_ref-WHO2015E_1-2"><a href="#cite_note-WHO2015E-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2016_2-1"><a href="#cite_note-AHFS2016-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Eflornithine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Eflornithine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eflornithine.svg.png" data-file-width="1030" data-file-height="633" data-file-type="drawing" height="123" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Eflornithine-3D-vdW.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eflornithine-3D-vdW.png" data-file-width="1100" data-file-height="827" data-file-type="bitmap" height="150" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Vaniqa, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Î±-difluoromethylornithine or DFMO</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/eflornithine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/eflornithine.html'" tppabs="https://www.drugs.com/monograph/eflornithine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eflornithine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eflornithine'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eflornithine" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eflornithine&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eflornithine&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eflornithine&SearchType=BasicSearch" class="external text external">Eflornithine</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>C</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>intravenous, topical</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>D11AX16<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=D11AX16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=D11AX16'" tppabs="https://www.whocc.no/atc_ddd_index/?code=D11AX16" class="external text external">WHO</a></span>)<span> </span>P01CX03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=P01CX03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=P01CX03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=P01CX03" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: â<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>100% (Intravenous)<br>Negligible (Dermal)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Not metabolised</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>8 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidneys</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-2,5-Diamino-2-(difluoromethyl)pentanoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=70052-12-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=70052-12-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=70052-12-9" class="external text external">70052-12-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3009'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3009" class="external text external">3009</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5176  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5176'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5176" class="external text external">5176</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB06243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB06243'" tppabs="https://www.drugbank.ca/drugs/DB06243" class="external text external">DB06243</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.2902.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.2902.html'" tppabs="http://www.chemspider.com/Chemical-Structure.2902.html" class="external text external">2902</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ZQN1G5V6SR  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ZQN1G5V6SR'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ZQN1G5V6SR" class="external text external">ZQN1G5V6SR</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07883'" tppabs="https://www.kegg.jp/entry/D07883" class="external text external">D07883</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41948  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41948'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41948" class="external text external">CHEBI:41948</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL830  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL830'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL830" class="external text external">ChEMBL830</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3020467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3020467'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3020467" class="external text external">DTXSID3020467</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>6</sub><span>H</span><sub>12</sub><span>F</span><sub>2</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">182.171</span><span>&nbsp;</span>gÂ·mol<sup>â1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29C%28N%29%28C%28%3DO%29O%29CCCN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29C%28N%29%28C%28%3DO%29O%29CCCN'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29C%28N%29%28C%28%3DO%29O%29CCCN" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">FC(F)C(N)(C(=O)O)CCCN</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C6H12F2N2O2/c7-4(8)6(10,5(11)12)2-1-3-9/h4H,1-3,9-10H2,(H,11,12)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:VLCYCQAOQCDTCN-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458957274&page2=Eflornithine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458957274&page2=Eflornithine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458957274&page2=Eflornithine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects when applied as a cream include rash, redness, and burning.<span class="mw-ref" id="cite_ref-AHFS2016_2-2"><a href="#cite_note-AHFS2016-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Side effects of the injectable form include bone marrow suppression, vomiting, and seizures.<span class="mw-ref" id="cite_ref-CDC2016_3-1"><a href="#cite_note-CDC2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is unclear if it is safe to use during pregnancy or breastfeeding.<span class="mw-ref" id="cite_ref-CDC2016_3-2"><a href="#cite_note-CDC2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is recommended typically for children over the age of 12.<span class="mw-ref" id="cite_ref-CDC2016_3-3"><a href="#cite_note-CDC2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<p>Eflornithine was developed in the 1970s and came into medical use in 1990.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_5-0"><a href="#cite_note-WHO21st-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> There is no generic version as of 2015 in the United States.<span class="mw-ref" id="cite_ref-Ric2015_6-0"><a href="#cite_note-Ric2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In the United States the injectable form can be obtained from the Centers for Disease Control and Prevention.<span class="mw-ref" id="cite_ref-CDC2016_3-4"><a href="#cite_note-CDC2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In the 1990s the cost of a course of treatment in Africa was US$210.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In regions of the world where the disease is common eflornithine is provided for free by the World Health Organization.<span class="mw-ref" id="cite_ref-WHO2016_8-0"><a href="#cite_note-WHO2016-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sleeping_sickness">Sleeping sickness</h3></summary>
    
<p>Sleeping sickness, or trypanosomiasis, is treated with <a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">pentamidine</a> or <a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">suramin</a> (depending on subspecies of parasite) delivered by intramuscular injection in the first phase of the disease, and with melarsoprol and eflornithine intravenous injection in the second phase of the disease. Efornithine is commonly given in combination with nifurtimox, which reduces the treatment time to 7 days of eflornithine infusions plus 10 days of oral nifurtimox tablets.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>Eflornithine is also effective in combination with other drugs, such as melarsoprol and nifurtimox. A study in 2005 compared the safety of eflornithine alone to melarsoprol and found eflornithine to be more effective and safe in treating second-stage sleeping sickness <i>Trypanosoma brucei gambiense</i>.<span class="mw-ref" id="cite_ref-Priotto2_10-0"><a href="#cite_note-Priotto2-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Eflornithine is not effective in the treatment of <i>Trypanosoma brucei rhodesiense</i> due to the parasite's low sensitivity to the drug. Instead, melarsoprol is used to treat <i>Trypanosoma brucei rhodesiense</i>.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Another randomized control trial in Uganda compared the efficacy of various combinations of these drugs and found that the nifurtimox-eflornithine combination was the most promising first-line theory regimen.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>A randomized control trial was conducted in Congo, CÃ´te d'Ivoire, the Democratic Republic of the Congo, and Uganda to determine if a 7-day intravenous regimen was as efficient as the standard 14-day regimen for new and relapsing cases. The results showed that the shortened regimen was efficacious in relapse cases, but was inferior to the standard regimen for new cases of the disease.<span class="mw-ref" id="cite_ref-Vincent,_Isabel_M.,_et_al._13-0"><a href="#cite_note-Vincent,_Isabel_M.,_et_al.-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Nifurtimox-eflornithine combination treatment (NECT) is an effective regimen for the treatment of second stage gambiense African trypanosomiasis.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-cdrwww_15-0"><a href="#cite_note-cdrwww-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Trypanosome_resistance">Trypanosome resistance</h4></summary>
    
<p>After its introduction to the market in the 1980s, eflornithine has replaced melarsoprol as the first line medication against Human African trypanosomiasis (HAT) due to its reduced toxicity to the host.<span class="mw-ref" id="cite_ref-Vincent,_Isabel_M.,_et_al._13-1"><a href="#cite_note-Vincent,_Isabel_M.,_et_al.-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> <i>Trypanosoma brucei</i> resistant to eflornithine was reported as early as the mid-1980s.<span class="mw-ref" id="cite_ref-Vincent,_Isabel_M.,_et_al._13-2"><a href="#cite_note-Vincent,_Isabel_M.,_et_al.-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>The gene TbAAT6, conserved in the genome of Trypanosomes, is believed to be responsible for the transmembrane transporter that brings eflornithine into the cell.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The loss of this gene due to specific mutations causes resistance to eflornithine in several trypanosomes.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> If eflornithine is prescribed to a patient with Human African trypanosomiasis caused by a trypanosome that contains a mutated or ineffective TbAAT6 gene, then the medication will be ineffective against the disease. Resistance to eflornithine has increased the use of melarsoprol despite its toxicity, which has been linked to the deaths of 5% of recipient HAT patients.<span class="mw-ref" id="cite_ref-Vincent,_Isabel_M.,_et_al._13-3"><a href="#cite_note-Vincent,_Isabel_M.,_et_al.-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Excess_facial_hair_in_women">Excess facial hair in women</h3></summary>
    
<p>The topical cream is indicated for treatment of facial hirsutism in women.<span class="mw-ref" id="cite_ref-NHS_and_UKMi_New_Medicines_Profile_18-0"><a href="#cite_note-NHS_and_UKMi_New_Medicines_Profile-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It is the only topical prescription treatment that slows the growth of facial hair.<span class="mw-ref" id="cite_ref-BalfourMcClellan2001_19-0"><a href="#cite_note-BalfourMcClellan2001-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It is applied in a thin layer twice daily, a minimum of eight hours between applications. In clinical studies with Vaniqa, 81% percent of women showed clinical improvement after twelve months of treatment.<span class="mw-ref" id="cite_ref-longterm_20-0"><a href="#cite_note-longterm-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Positive results were seen after eight weeks.<span class="mw-ref" id="cite_ref-apple_21-0"><a href="#cite_note-apple-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> However, discontinuation of the cream caused regrowth of hair back to baseline levels within 8 weeks.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Vaniqa treatment significantly reduces the psychological burden of facial hirsutism.<span class="mw-ref" id="cite_ref-Jackson_J,_Caro_JJ,_Caro_G,_Garfield_F,_Huber_F,_Zhou_W,_Lin_CS,_Shander_D,_Schrode_K,_and_the_Eflornithine_HCl_Study_Group_23-0"><a href="#cite_note-Jackson_J,_Caro_JJ,_Caro_G,_Garfield_F,_Huber_F,_Zhou_W,_Lin_CS,_Shander_D,_Schrode_K,_and_the_Eflornithine_HCl_Study_Group-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Chemo_preventative_therapy">Chemo preventative therapy</h3></summary>
    
<p>It has been noted that ornithine decarboxylase (ODC) exhibits high activity in tumor cells, promoting cell growth and division, while absence of ODC activity leads to depletion of putrescine, causing impairment of RNA and DNA synthesis. Typically, drugs that inhibit cell growth are considered candidates for cancer therapy, so eflornithine was naturally believed to have potential utility as an anti-cancer agent. By inhibiting ODC, eflornithine inhibits cell growth and division of both cancerous and noncancerous cells.</p>

<p>However, several clinical trials demonstrated minor results.<span class="mw-ref" id="cite_ref-Paul,_F._24-0"><a href="#cite_note-Paul,_F.-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> It was found that inhibition of ODC by eflornithine does not kill proliferating cells, making eflornithine ineffective as a chemotherapeutic agent. The inhibition of the formation of polyamines by ODC activity can be ameliorated by dietary and bacterial means because high concentrations are found in cheese, red meat, and some intestinal bacteria, providing reserves if ODC is inhibited.<span class="mw-ref" id="cite_ref-Gerner,_Eugene_W._25-0"><a href="#cite_note-Gerner,_Eugene_W.-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Although the role of polyamines in carcinogenesis is still unclear, polyamine synthesis has been supported to be more of a causative agent rather than an associative effect in cancer.<span class="mw-ref" id="cite_ref-Paul,_F._24-1"><a href="#cite_note-Paul,_F.-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>Other studies have suggested that eflornithine can still aid in some chemoprevention by lowering polyamine levels in colorectal mucosa, with additional strong preclinical evidence available for application of eflornithine in colorectal and skin carcinogenesis.<span class="mw-ref" id="cite_ref-Paul,_F._24-2"><a href="#cite_note-Paul,_F.-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-Gerner,_Eugene_W._25-1"><a href="#cite_note-Gerner,_Eugene_W.-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> This has made eflornithine a supported chemopreventive therapy specifically for colon cancer in combination with other medications. Several additional studies have found that eflornithine in combination with other compounds decreases the carcinogen concentrations of ethylnitrosourea, dimethylhydrazine, azoxymethane, methylnitrosourea, and hydroxybutylnitrosamine in the brain, spinal cord, intestine, mammary gland, and urinary bladder.<span class="mw-ref" id="cite_ref-Gerner,_Eugene_W._25-2"><a href="#cite_note-Gerner,_Eugene_W.-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Topical">Topical</h3></summary>
    
<p>Topical use is contraindicated in people hypersensitive to eflornithine or to any of the excipients.<span class="mw-ref" id="cite_ref-emc.medicines.org.uk_26-0"><a href="#cite_note-emc.medicines.org.uk-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>Throughout clinical trials, data from a limited number of exposed pregnancies indicate that there is no clinical evidence that treatment with Vaniqa adversely affects pregnant women or fetuses.<span class="mw-ref" id="cite_ref-emc.medicines.org.uk_26-1"><a href="#cite_note-emc.medicines.org.uk-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="By_mouth">By mouth</h3></summary>
    
<p>When taken by mouth the risk-benefit should be assessed in people with impaired renal function or pre-existing hematologic abnormalities, as well as those with eighth-cranial-nerve impairment.<span class="mw-ref" id="cite_ref-Ornidyl_Drug_Information_27-0"><a href="#cite_note-Ornidyl_Drug_Information-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span>
Adequate and well-controlled studies with eflornithine have not been performed regarding pregnancy in humans. Eflornithine should only be used during pregnancy if the potential benefit outweighs the potential risk to the fetus. However, since African trypanosomiasis has a high mortality rate if left untreated, treatment with eflornithine may justify any potential risk to the fetus.<span class="mw-ref" id="cite_ref-Ornidyl_Drug_Information_27-1"><a href="#cite_note-Ornidyl_Drug_Information-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Eflornithine is not genotoxic; no tumour-inducing effects have been observed in carcinogenicity studies, including one photocarcinogenicity study.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> No teratogenic effects have been detected.<span class="mw-ref" id="cite_ref-:0_29-0"><a href="#cite_note-:0-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Topical_2">Topical</h3></summary>
    
<p>The topical form of elflornithine is sold under the brand name Vaniqa . The most frequently reported side effect is acne (7â14%). Other side effects commonly (&gt; 1%) reported are skin problems, such as skin reactions from in-growing hair, hair loss, burning, stinging or tingling sensations, dry skin, itching, redness or rash.<span class="mw-ref" id="cite_ref-vaniqa.com_30-0"><a href="#cite_note-vaniqa.com-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Intravenous">Intravenous</h3></summary>
    
<p>The intravenous dosage form of eflornithine is sold under the brand name Ornidyl. Most side effects related to systemic use through injection are transient and reversible by discontinuing the drug or decreasing the dose. Hematologic abnormalities occur frequently, ranging from 10â55%. These abnormalities are dose-related and are usually reversible. Thrombocytopenia is thought to be due to a production defect rather than to peripheral destruction. Seizures were seen in approximately 8% of patients, but may be related to the disease state rather than the drug. Reversible hearing loss has occurred in 30â70% of patients receiving long-term therapy (more than 4â8 weeks of therapy or a total dose of &gt;300<span>&nbsp;</span>grams); high-frequency hearing is lost first, followed by middle- and low-frequency hearing. Because treatment for African trypanosomiasis is short-term, patients are unlikely to experience hearing loss.<span class="mw-ref" id="cite_ref-vaniqa.com_30-1"><a href="#cite_note-vaniqa.com-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Topical_3">Topical</h3></summary>
    
<p>No interaction studies with the topical form have been performed.<span class="mw-ref" id="cite_ref-emc.medicines.org.uk_26-2"><a href="#cite_note-emc.medicines.org.uk-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Description">Description</h3></summary>
    
<p>Eflornithine is a "suicide inhibitor," irreversibly binding to ornithine decarboxylase (ODC) and preventing the natural substrate ornithine from accessing the active site (Figure 1). Within the active site of ODC, eflornithine undergoes decarboxylation with the aid of cofactor pyridoxal 5'-phosphate (PLP). Because of its additional difluoromethyl group in comparison to ornithine, eflornithine is able to bind to a neighboring Cys-360 residue, permanently remaining fixated within the active site.<span class="mw-ref" id="cite_ref-:0_29-1"><a href="#cite_note-:0-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>During the reaction, eflornithine's decarboxylation mechanism is analogous to that of ornithine in the active site, where <a href="Transamination.htm" tppabs="https://ptable.com/wiki/compounds/A/Transamination" title="Transamination">transamination</a> occurs with PLP followed by decarboxylation. During the event of decarboxylation, the fluoride atoms attached to the additional methyl group pull the resulting negative charge from the release of carbon dioxide, causing a fluoride ion to be released. In the natural substrate of ODC, the ring of PLP accepts the electrons that result from the release of CO<sub>2</sub>.</p>

<p>The remaining <a href="Fluoride.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoride" title="Fluoride">fluoride</a> atom that resides attached to the additional methyl group creates an electrophilic carbon that is attacked by the nearby thiol group of Cys-360, allowing eflornithine to remain permanently attached to the enzyme following the release of the second fluoride atom and transimination.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Evidence">Evidence</h3></summary>
    

<p>The reaction mechanism of <i>Trypanosoma brucei'</i>s ODC with ornithine was characterized by UV-VIS spectroscopy in order to identify unique intermediates that occurred during the reaction. The specific method of multiwavelength stopped-flow spectroscopy utilized monochromatic light and fluorescence to identify five specific intermediates due to changes in absorbance measurements.<span class="mw-ref" id="cite_ref-name_31-0"><a href="#cite_note-name-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> The steady-state turnover number, k<sub>cat</sub>, of ODC was calculated to be 0.5<span>&nbsp;</span>s<sup><span>â</span>1</sup> at 4<span>&nbsp;</span>Â°C.<span class="mw-ref" id="cite_ref-name_31-1"><a href="#cite_note-name-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> From this characterization, the rate-limiting step was determined to be the release of the product putrescine from ODC's reaction with ornithine.
In studying the hypothetical reaction mechanism for eflornithine, information collected from radioactive peptide and eflornithine mapping, high pressure liquid chromatography, and gas phase peptide sequencing suggested that Lys-69 and Cys-360 are covalently bound to eflornithine in <i>T. brucei</i> ODC's active site.<span class="mw-ref" id="cite_ref-mech_32-0"><a href="#cite_note-mech-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Utilizing fast-atom bombardment mass spectrometry (FAB-MS), the structural conformation of eflornithine following its interaction with ODC was determined to be (<i>S</i>)-((2-(1-pyrroline-methyl) cysteine, a cyclic imine adduct. Presence of this particular product was supported by the possibility to further reduce the end product to (<i>S</i>)-((2-pyrrole) methyl) cysteine in the presence of <a href="Sodium_borohydride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_borohydride" title="Sodium borohydride">NaBH<sub>4</sub></a> and oxidize the end product to (<i>S</i>)-((2-pyrrolidine) methyl) cysteine (Figure 2).<span class="mw-ref" id="cite_ref-mech_32-1"><a href="#cite_note-mech-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Active_site">Active site</h3></summary>
    

<p>Eflornithine's suicide inhibition of ODC physically blocks the natural substrate ornithine from accessing the active site of the enzyme (Figure 3).<span class="mw-ref" id="cite_ref-:0_29-2"><a href="#cite_note-:0-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> There are two distinct active sites formed by the homodimerization of ornithine decarboxylase. The size of the opening to the active site is approximately 13.6 Ã. When these openings to the active site are blocked, there are no other ways through which ornithine can enter the active site. During the intermediate stage of eflornithine with PLP, its position near Cys-360 allows an interaction to occur. As the phosphate of PLP is stabilized by Arg 277 and a Gly-rich loop (235-237), the difluoromethyl group of eflornithine is able to interact and remain fixated to both Cys-360 and PLP prior to transimination.
As shown in the figure, the pyrroline ring interferes with ornithine's entry (Figure 4). Eflornithine will remain permanently bound in this position to Cys-360. As ODC has two active sites, two eflornithine molecules are required to completely inhibit ODC from ornithine decarboxylation.</p>

<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 235px;"><div class="thumb" style="width: 230px; height: 230px;"><figure-inline><img src="../I/m/lossless-page1-132px-Ornithine_and_Eflornithine_Comparison_Structures.tiff.png" tppabs="https://ptable.com/wiki/compounds/I/m/lossless-page1-132px-Ornithine_and_Eflornithine_Comparison_Structures.tiff.png" data-file-width="330" data-file-height="500" data-file-type="bitmap" height="200" width="132"></figure-inline></div><div class="gallerytext">Figure 1<br>(A) 3D structure of L-Ornithine (B) 3D structure of Eflornithine. This molecule is similar to the structure of L-Ornithine, but its alpha-difluoromethyl group allows interaction with Cys-360 in the active site</div></li>
<li class="gallerybox" style="width: 235px;"><div class="thumb" style="width: 230px; height: 230px;"><figure-inline><img src="../I/m/Eflornithine_Reaction_Mechansim.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eflornithine_Reaction_Mechansim.png" data-file-width="2766" data-file-height="1571" data-file-type="bitmap" height="114" width="200"></figure-inline></div><div class="gallerytext">Eflornithine ODC reaction mechanism</div></li>
<li class="gallerybox" style="width: 235px;"><div class="thumb" style="width: 230px; height: 230px;"><figure-inline><img src="../I/m/DFMO_inhibitor_product_evidence.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/DFMO_inhibitor_product_evidence.svg.png" data-file-width="512" data-file-height="532" data-file-type="drawing" height="200" width="192"></figure-inline></div><div class="gallerytext">Figure 2 <br>Experimental Evidence for Eflornithine End Product<span class="mw-ref" id="cite_ref-mech_32-2"><a href="#cite_note-mech-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></div></li>
<li class="gallerybox" style="width: 235px;"><div class="thumb" style="width: 230px; height: 230px;"><figure-inline><img src="../I/m/Eflornithine_in_the_Active_Site.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eflornithine_in_the_Active_Site.png" data-file-width="325" data-file-height="537" data-file-type="bitmap" height="200" width="121"></figure-inline></div><div class="gallerytext">Figure 3 <br>Active Site of ODC Formed by Homodimerization (Green and White Surface Structures) (A) Ornithine in the Active Site of ODC, Cys-360 highlighted in yellow (B) Product of Eflornithine Decarboxylation bound to Cys 360 (highlighted in yellow). The pyrroline ring blocks ornithine from entering the active site<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></div></li>
</ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Eflornithine was initially developed for cancer treatment at Merrell Dow Research Institute in the late 1970s, but was found to be ineffective in treating malignancies. However, it was discovered to be highly effective in reducing hair growth,<span class="mw-ref" id="cite_ref-Wolf_34-0"><a href="#cite_note-Wolf-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> as well as in the treatment of  African trypanosomiasis (sleeping sickness),<span class="mw-ref" id="cite_ref-Pepin_J,_Milord_F,_Guern_C,_Schechter_PJ_1987._1431â3_35-0"><a href="#cite_note-Pepin_J,_Milord_F,_Guern_C,_Schechter_PJ_1987._1431â3-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> especially the West African form (Trypanosoma brucei gambiense).</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hirsutism">Hirsutism</h3></summary>
    
<p>In the 1980s, Gillette was awarded a patent for the discovery that topical application of eflornithine HCl cream inhibits hair growth. In the 1990s, Gillette conducted dose-ranging studies with eflornithine in hirsute women that demonstrated that the drug slows the rate of facial hair growth. Gillette then filed a patent for the formulation of eflornithine cream. In July 2000, the U.S. Food and Drug Administration (FDA) granted a New Drug Application for Vaniqa. The following year, the European Commission issued its Marketing Authorisation.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sleeping_sickness_treatment">Sleeping sickness treatment</h3></summary>
    
<p>The drug was registered for the treatment of gambiense sleeping sickness on November 28, 1990.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> However, in 1995 Aventis (now Sanofi-Aventis) stopped producing the drug, whose main market was African countries, because it did not make a profit.<span class="mw-ref" id="cite_ref-MSF_37-0"><a href="#cite_note-MSF-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>

<p>In 2001, Aventis and the WHO formed a five-year partnership, during which more than 320,000 vials of pentamidine, over 420,000 vials of melarsoprol, and over 200,000 bottles of eflornithine were produced by Aventis, to be given to the WHO and distributed by the association MÃ©decins sans FrontiÃ¨res (also known as Doctors Without Borders)<span class="mw-ref" id="cite_ref-en.sanofi-aventis.com_38-0"><a href="#cite_note-en.sanofi-aventis.com-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> in countries where sleeping sickness is endemic.</p>

<p>According to MÃ©decins sans FrontiÃ¨res, this only happened after "years of international pressure," and coinciding with the period when media attention was generated because of the launch of another eflornithine-based product (Vaniqa, for the prevention of facial-hair in women),<span class="mw-ref" id="cite_ref-MSF_37-1"><a href="#cite_note-MSF-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> while its life-saving formulation (for sleeping sickness) was not being produced.</p>

<p>From 2001 (when production was restarted) through 2006, 14 million diagnoses were made. This greatly contributed to stemming the spread of sleeping sickness, and to saving nearly 110,000 lives.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/EflornithineBottle.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/EflornithineBottle.jpg" data-file-width="614" data-file-height="918" data-file-type="bitmap" height="329" width="220"><div class="thumbcaption" style="text-align: left">VIal of eflornithine</div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Vaniqa is a cream, which is white to off-white in colour. It is supplied in tubes of 30 g and 60 g in Europe.<span class="mw-ref" id="cite_ref-vaniqa.com_30-2"><a href="#cite_note-vaniqa.com-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Vaniqa contains 15% w/w eflornithine hydrochloride monohydrate, corresponding to 11.5% w/w anhydrous eflornithine (EU), respectively 13.9% w/w anhydrous eflornithine hydrochloride (U.S.), in a cream for topical administration.</p>

<p>Ornidyl, intended for injection, was supplied in the strength of 200<span>&nbsp;</span>mg eflornithine hydrochloride per ml.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<p>In 2000, the cost for the 14-day regimen was US$500; a price that many in countries where the disease is common cannot afford.<span class="mw-ref" id="cite_ref-Vincent,_Isabel_M.,_et_al._13-4"><a href="#cite_note-Vincent,_Isabel_M.,_et_al.-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Market">Market</h3></summary>
    
<p>Vaniqa, granted marketing approval by the US FDA, as well as by the European Commission<span class="mw-ref" id="cite_ref-Vaniqa_Training_Programme_Module_5_41-0"><a href="#cite_note-Vaniqa_Training_Programme_Module_5-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> among others, is currently the only topical prescription treatment that slows the growth of facial hair.<span class="mw-ref" id="cite_ref-BalfourMcClellan2001_19-1"><a href="#cite_note-BalfourMcClellan2001-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Besides being a non-mechanical and non-cosmetic treatment, it is the only non-hormonal and non-systemic prescription option available for women who suffer from facial hirsutism.<span class="mw-ref" id="cite_ref-NHS_and_UKMi_New_Medicines_Profile_18-1"><a href="#cite_note-NHS_and_UKMi_New_Medicines_Profile-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Vaniqa is marketed by Almirall in Europe, SkinMedica in the US, Triton in Canada, Medison in Israel, and Menarini in Australia.<span class="mw-ref" id="cite_ref-Vaniqa_Training_Programme_Module_5_41-1"><a href="#cite_note-Vaniqa_Training_Programme_Module_5-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Ornidyl, the injectable form of eflornithine hydrochloride, is licensed by Sanofi-Aventis, but is currently discontinued in the US.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>
<div style="clear:both;"></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-WHO2015E-1"> <span id="mw-reference-text-cite_note-WHO2015E-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf'" tppabs="http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf" class="external text external">"19th WHO Model List of Essential Medicines (April 2015)"</a> <span class="cs1-format">(PDF)</span>. WHO. April 2015. <a href="javascript:if(confirm('https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf'" tppabs="https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on May 13, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">May 10,</span> 2015</span>.</cite></span></li><li id="cite_note-AHFS2016-2"> <span id="mw-reference-text-cite_note-AHFS2016-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/eflornithine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/eflornithine.html'" tppabs="https://www.drugs.com/monograph/eflornithine.html" class="external text external">"Eflornithine"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161220223444/https://www.drugs.com/monograph/eflornithine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220223444/https://www.drugs.com/monograph/eflornithine.html'" tppabs="https://web.archive.org/web/20161220223444/https://www.drugs.com/monograph/eflornithine.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">28 November</span> 2016</span>.</cite></span></li><li id="cite_note-CDC2016-3"> <span id="mw-reference-text-cite_note-CDC2016-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cdc.gov/parasites/sleepingsickness/health_professionals/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/parasites/sleepingsickness/health_professionals/'" tppabs="https://www.cdc.gov/parasites/sleepingsickness/health_professionals/" class="external text external">"CDC - African Trypanosomiasis - Resources for Health Professionals"</a>. <i>www.cdc.gov</i>. 10 August 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20161128180459/http://www.cdc.gov/parasites/sleepingsickness/health_professionals/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161128180459/http://www.cdc.gov/parasites/sleepingsickness/health_professionals/'" tppabs="https://web.archive.org/web/20161128180459/http://www.cdc.gov/parasites/sleepingsickness/health_professionals/" class="external text external">Archived</a> from the original on 28 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 December</span> 2016</span>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFMarcondes2016" class="citation book cs1">Marcondes, Carlos Brisola (2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292'" tppabs="https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292" class="external text external"><i>Arthropod Borne Diseases</i></a>. Springer. p.<span>&nbsp;</span>292. ISBN<span>&nbsp;</span><bdi>9783319138848</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910144448/https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910144448/https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292'" tppabs="https://web.archive.org/web/20170910144448/https://books.google.com/books?id=Qs55DQAAQBAJ&pg=PA292" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-WHO21st-5"> <span id="mw-reference-text-cite_note-WHO21st-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-Ric2015-6"> <span id="mw-reference-text-cite_note-Ric2015-6" class="mw-reference-text"><cite id="CITEREFHamilton2015" class="citation book cs1">Hamilton, Richart (2015). <i>Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition</i>. Jones &amp; Bartlett Learning. p.<span>&nbsp;</span>192. ISBN<span>&nbsp;</span><bdi>9781284057560</bdi>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFGraysonCroweMcCarthyMills2010" class="citation book cs1">Grayson, M. Lindsay; Crowe, Suzanne M.; McCarthy, James S.; Mills, John; Mouton, Johan W.; Norrby, S. Ragnar; Paterson, David L.; Pfaller, Michael A. (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194'" tppabs="https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194" class="external text external"><i>Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs</i></a>. CRC Press. p.<span>&nbsp;</span>2194. ISBN<span>&nbsp;</span><bdi>9781444147520</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910144448/https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910144448/https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194'" tppabs="https://web.archive.org/web/20170910144448/https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2194" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-WHO2016-8"> <span id="mw-reference-text-cite_note-WHO2016-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/mediacentre/factsheets/fs259/en/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/mediacentre/factsheets/fs259/en/'" tppabs="http://www.who.int/mediacentre/factsheets/fs259/en/" class="external text external">"Trypanosomiasis, human African (sleeping sickness)"</a>. <i>World Health Organization</i>. February 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20161204153318/http://www.who.int/mediacentre/factsheets/fs259/en/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161204153318/http://www.who.int/mediacentre/factsheets/fs259/en/'" tppabs="https://web.archive.org/web/20161204153318/http://www.who.int/mediacentre/factsheets/fs259/en/" class="external text external">Archived</a> from the original on 4 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">7 December</span> 2016</span>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFBabokhov_P2013" class="citation journal cs1">Babokhov P;  et al. (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453" class="external text external">"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis"</a>. <i>Pathog Glob Health</i>. <b>107</b> (5): 242â52. doi:<a href="javascript:if(confirm('https://doi.org/10.1179%2F2047773213Y.0000000105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1179%2F2047773213Y.0000000105'" tppabs="https://doi.org/10.1179%2F2047773213Y.0000000105" class="external text external">10.1179/2047773213Y.0000000105</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001453" class="external text external">4001453</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23916333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23916333'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23916333" class="external text external">23916333</a>.</cite></span></li><li id="cite_note-Priotto2-10"> <span id="mw-reference-text-cite_note-Priotto2-10" class="mw-reference-text"><cite id="CITEREFPriotto2006" class="citation journal cs1">Priotto, Gerardo;  et al. (December 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208" class="external text external">"Three drug combinations for late-stage <i>Trypanosoma brucei gambiense</i> sleeping sickness: a randomized clinical trial in Uganda"</a>. <i>PLoS Clinical Trials</i>. <b>1</b> (8): e39. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pctr.0010039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pctr.0010039'" tppabs="https://doi.org/10.1371%2Fjournal.pctr.0010039" class="external text external">10.1371/journal.pctr.0010039</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687208" class="external text external">1687208</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17160135  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17160135'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17160135" class="external text external">17160135</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFLutjeSeixasKennedy2013" class="citation journal cs1">Lutje, Vittoria; Seixas, Jorge; Kennedy, Adrian (2013-06-28). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745" class="external text external">"Chemotherapy for second-stage Human African trypanosomiasis"</a>. <i>Cochrane Database of Systematic Reviews</i> (6): CD006201. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.cd006201.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.cd006201.pub3'" tppabs="https://doi.org/10.1002%2F14651858.cd006201.pub3" class="external text external">10.1002/14651858.cd006201.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532745" class="external text external">6532745</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23807762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23807762'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23807762" class="external text external">23807762</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFChappuis2005" class="citation journal cs1">Chappuis F,  et al. (2005). <a href="javascript:if(confirm('https://doi.org/10.1086/432576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/432576'" tppabs="https://doi.org/10.1086/432576" class="external text external">"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis"</a>. <i>Clinical Infectious Diseases</i>. <b>41</b> (5): 748â751. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F432576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F432576'" tppabs="https://doi.org/10.1086%2F432576" class="external text external">10.1086/432576</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16080099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16080099'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16080099" class="external text external">16080099</a>.</cite></span></li><li id="cite_note-Vincent,_Isabel_M.,_et_al.-13"> <span id="mw-reference-text-cite_note-Vincent,_Isabel_M.,_et_al.-13" class="mw-reference-text"><cite id="CITEREFVincent2010" class="citation journal cs1">Vincent, Isabel M.;  et al. (November 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269" class="external text external">"A molecular mechanism for eflornithine resistance in African trypanosomes"</a>. <i>PLoS Pathogens</i>. <b>6</b> (11): e1001204. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.ppat.1001204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.ppat.1001204'" tppabs="https://doi.org/10.1371%2Fjournal.ppat.1001204" class="external text external">10.1371/journal.ppat.1001204</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991269" class="external text external">2991269</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21124824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21124824'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21124824" class="external text external">21124824</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/trypanosomiasis_african/research/combination_treatment/en/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/trypanosomiasis_african/research/combination_treatment/en/'" tppabs="http://www.who.int/trypanosomiasis_african/research/combination_treatment/en/" class="external text external">"Nifurtimox-eflornithine combination treatment for sleeping sickness (human African trypanosomiasis): WHO wraps up training of key health care personnel"</a>. World Health Organization. March 23, 2010.</cite></span></li><li id="cite_note-cdrwww-15"> <span id="mw-reference-text-cite_note-cdrwww-15" class="mw-reference-text"><cite id="CITEREFFrancoPereDiarraRuiz-Postigo2012" class="citation journal cs1">Franco, Jose; Pere, Simarro; Diarra; Ruiz-Postigo; Samo; Jannin (2012). <a href="javascript:if(confirm('http://cdrwww.who.int/selection_medicines/committees/expert/19/applications/NE_6551_pub1.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cdrwww.who.int/selection_medicines/committees/expert/19/applications/NE_6551_pub1.pdf'" tppabs="http://cdrwww.who.int/selection_medicines/committees/expert/19/applications/NE_6551_pub1.pdf" class="external text external">"Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis"</a> <span class="cs1-format">(PDF)</span>. <i>Research and Reports in Tropical Medicine</i>. <b>3</b>: 93â101. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FRRTM.S34399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FRRTM.S34399'" tppabs="https://doi.org/10.2147%2FRRTM.S34399" class="external text external">10.2147/RRTM.S34399</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067772'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067772" class="external text external">6067772</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30100776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30100776'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30100776" class="external text external">30100776</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFSayÃ©2014" class="citation journal cs1">SayÃ© M,  et al. (2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872" class="external text external">"Proline Modulates the Trypanosoma cruzi Resistance to Reactive Oxygen Species and Drugs through a Novel D, L-Proline Transporter"</a>. <i>PLoS ONE</i>. <b>9</b> (3): e92028. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2014PLoSO...992028S  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2014PLoSO...992028S'" tppabs="https://ui.adsabs.harvard.edu/abs/2014PLoSO...992028S" class="external text external">2014PLoSO...992028S</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0092028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0092028'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0092028" class="external text external">10.1371/journal.pone.0092028</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956872" class="external text external">3956872</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24637744  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24637744'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24637744" class="external text external">24637744</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text">Barrett, M. P., et al. "Human African trypanosomiasis: pharmacological reâengagement with a neglected disease." British Journal of Pharmacology 152.8 (2007): 1155-1171.</span></li><li id="cite_note-NHS_and_UKMi_New_Medicines_Profile-18"> <span id="mw-reference-text-cite_note-NHS_and_UKMi_New_Medicines_Profile-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100215120040/http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100215120040/http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf'" tppabs="https://web.archive.org/web/20100215120040/http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf" class="external text external">"NHS and UKMi New Medicines Profile"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf'" tppabs="http://www.ukmi.nhs.uk/NewMaterial/html/docs/EflornithineNMP0504b.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2010-02-15.</cite></span></li><li id="cite_note-BalfourMcClellan2001-19"> <span id="mw-reference-text-cite_note-BalfourMcClellan2001-19" class="mw-reference-text"><cite id="CITEREFBalfourMcClellan2001" class="citation journal cs1">Balfour JA, McClellan K (June 2001). "Topical Eflornithine". <i>Am J Clin Dermatol</i>. <b>2</b> (3): 197â201. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00128071-200102030-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00128071-200102030-00009'" tppabs="https://doi.org/10.2165%2F00128071-200102030-00009" class="external text external">10.2165/00128071-200102030-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11705097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11705097'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11705097" class="external text external">11705097</a>.</cite></span></li><li id="cite_note-longterm-20"> <span id="mw-reference-text-cite_note-longterm-20" class="mw-reference-text"><cite id="CITEREFSchrode_KHuber_FStaszak_JAltman_DJ" class="citation journal cs1">Schrode K; Huber F; Staszak J; Altman DJ. "Evaluation of the long-term safety of eflornithine 15% cream in the treatment of women with excessive facial hair. Presented at 58th Annual Meeting of the Academy of Dermatology 2000, 10â15 March, San Francisco; USA, Poster 294". the Eflornithine Study Group.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-apple-21"> <span id="mw-reference-text-cite_note-apple-21" class="mw-reference-text"><cite id="CITEREFSchrode_K,_Huber_FStaszak,_JAltman_DJ,_Shander_DMorton_J,_the_Eflornithine_Study_Group" class="citation journal cs1">Schrode K, Huber F; Staszak, J; Altman DJ, Shander D &amp; Morton J, the Eflornithine Study Group. "Randomized, double-blind, vehicle-controlled safety and efficacy evaluation of eflornithine 15% cream in the treatment of women with excessive facial hair. Presented at 58th Annual Meeting of the Academy of Dermatology 2000, 10â15 March, San Francisco; USA, Poster 291".</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFWolfShanderHuberJackson2007" class="citation journal cs1">Wolf, John E.; Shander, Douglas; Huber, Ferdinand; Jackson, Joseph; Lin, Chen-Sheng; Mathes, Barbara M.; Schrode, Kathy; the Eflornithine HCl Study Group (2007-01-01). "Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl<span>&nbsp;</span>13.9% cream in the treatment of women with facial hair". <i>International Journal of Dermatology</i>. <b>46</b> (1): 94â98. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x'" tppabs="https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x" class="external text external">10.1111/j.1365-4632.2006.03079.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1365-4632  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1365-4632'" tppabs="https://www.worldcat.org/issn/1365-4632" class="external text external">1365-4632</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17214730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17214730'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17214730" class="external text external">17214730</a>.</cite></span></li><li id="cite_note-Jackson_J,_Caro_JJ,_Caro_G,_Garfield_F,_Huber_F,_Zhou_W,_Lin_CS,_Shander_D,_Schrode_K,_and_the_Eflornithine_HCl_Study_Group-23"> <span id="mw-reference-text-cite_note-Jackson_J,_Caro_JJ,_Caro_G,_Garfield_F,_Huber_F,_Zhou_W,_Lin_CS,_Shander_D,_Schrode_K,_and_the_Eflornithine_HCl_Study_Group-23" class="mw-reference-text"><cite id="CITEREFJackson_J,_Caro_JJCaro_G,_Garfield_FHuber_F,_Zhou_WLin_CS,_Shander_D" class="citation journal cs1">Jackson J, Caro JJ; Caro G, Garfield F; Huber F, Zhou W; Lin CS, Shander D &amp; Schrode K. "The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism. Int J Derm 2007; 46: 976-981". the Eflornithine HCl Study Group.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-Paul,_F.-24"> <span id="mw-reference-text-cite_note-Paul,_F.-24" class="mw-reference-text">Paul, F. "Revival of 2-(difluoromethyl) ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent." Biochemical Society Transactions 35.Pt 2 (2007): 353-355.</span></li><li id="cite_note-Gerner,_Eugene_W.-25"> <span id="mw-reference-text-cite_note-Gerner,_Eugene_W.-25" class="mw-reference-text"><cite id="CITEREFGernerMeyskens2004" class="citation journal cs1">Gerner EW, Meyskens FL (2004). <a href="javascript:if(confirm('http://www.escholarship.org/uc/item/1sc3c2gj  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.escholarship.org/uc/item/1sc3c2gj'" tppabs="http://www.escholarship.org/uc/item/1sc3c2gj" class="external text external">"Polyamines and cancer: old molecules, new understanding"</a>. <i>Nature Reviews Cancer</i>. <b>4</b> (10): 781â792. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrc1454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrc1454'" tppabs="https://doi.org/10.1038%2Fnrc1454" class="external text external">10.1038/nrc1454</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15510159  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15510159'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15510159" class="external text external">15510159</a>.</cite></span></li><li id="cite_note-emc.medicines.org.uk-26"> <span id="mw-reference-text-cite_note-emc.medicines.org.uk-26" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20091205163254/http://emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%25+cream/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20091205163254/http://emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%25+cream/'" tppabs="https://web.archive.org/web/20091205163254/http://emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%25+cream/" class="external text external">"Vaniqa Summary of Product Characteristics 2008"</a>. Archived from <a href="javascript:if(confirm('http://www.emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%+cream  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%+cream'" tppabs="http://www.emc.medicines.org.uk/medicine/21243/SPC/Vaniqa+11.5%+cream" class="external text external">the original</a> on 2009-12-05.</cite></span></li><li id="cite_note-Ornidyl_Drug_Information-27"> <span id="mw-reference-text-cite_note-Ornidyl_Drug_Information-27" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110607070234/http://www.drugs.com/mmx/ornidyl.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110607070234/http://www.drugs.com/mmx/ornidyl.html'" tppabs="https://web.archive.org/web/20110607070234/http://www.drugs.com/mmx/ornidyl.html" class="external text external">"Ornidyl Drug Information"</a>. Archived from <a href="javascript:if(confirm('https://www.drugs.com/mmx/ornidyl.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/mmx/ornidyl.html'" tppabs="https://www.drugs.com/mmx/ornidyl.html" class="external text external">the original</a> on 2011-06-07.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFMalhotraNoveckBehrPalmisano2001" class="citation journal cs1">Malhotra B, Noveck R, Behr D, Palmisano M (September 2001). <a href="javascript:if(confirm('http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract'" tppabs="http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract" class="external text external">"Percutaneous absorption and pharmacokinetics of Eflornithine HCI 13.9% cream in women with unwanted facial hair"</a>. <i>J Clin Pharmacol</i>. <b>41</b> (9): 972â978. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F00912700122010951  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F00912700122010951'" tppabs="https://doi.org/10.1177%2F00912700122010951" class="external text external">10.1177/00912700122010951</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11549102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11549102'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11549102" class="external text external">11549102</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20161112021229/http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161112021229/http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract'" tppabs="https://web.archive.org/web/20161112021229/http://onlinelibrary.wiley.com/doi/10.1177/009127000104100907/abstract" class="external text external">Archived</a> from the original on 2016-11-12.</cite></span></li><li id="cite_note-:0-29"> <span id="mw-reference-text-cite_note-:0-29" class="mw-reference-text"><cite class="citation journal cs1">"Vaniqa Product Monograph".</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-vaniqa.com-30"> <span id="mw-reference-text-cite_note-vaniqa.com-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf'" tppabs="http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf" class="external text external">"Vaniqa US Patient Information Leaflet"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20100215071210/http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100215071210/http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf'" tppabs="https://web.archive.org/web/20100215071210/http://www.vaniqa.com/files/Vaniqa_Prescription_Info.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2010-02-15.</cite></span></li><li id="cite_note-name-31"> <span id="mw-reference-text-cite_note-name-31" class="mw-reference-text"><cite id="CITEREFBrooksPhillips,_MA1997" class="citation journal cs1">Brooks, HB; Phillips, MA (Dec 9, 1997). "Characterization of the reaction mechanism for <i>Trypanosoma brucei</i> ornithine decarboxylase by multiwavelength stopped-flow spectroscopy". <i>Biochemistry</i>. <b>36</b> (49): 15147â55. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fbi971652b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fbi971652b'" tppabs="https://doi.org/10.1021%2Fbi971652b" class="external text external">10.1021/bi971652b</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9398243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9398243'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9398243" class="external text external">9398243</a>.</cite></span></li><li id="cite_note-mech-32"> <span id="mw-reference-text-cite_note-mech-32" class="mw-reference-text"><cite id="CITEREFPoulinLu,_LAckermann,_BBey,_P1992" class="citation journal cs1">Poulin, R; Lu, L; Ackermann, B; Bey, P; Pegg, AE (Jan 5, 1992). "Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by <span>Î±</span>-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites". <i>The Journal of Biological Chemistry</i>. <b>267</b> (1): 150â8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1730582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1730582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1730582" class="external text external">1730582</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFGrishinOstermanBrooksPhillips1999" class="citation journal cs1">Grishin, NV; Osterman, AL; Brooks, HB; Phillips, MA; Goldsmith, EJ (16 November 1999). "X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine". <i>Biochemistry</i>. <b>38</b> (46): 15174â84. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fbi9915115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fbi9915115'" tppabs="https://doi.org/10.1021%2Fbi9915115" class="external text external">10.1021/bi9915115</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10563800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10563800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10563800" class="external text external">10563800</a>.</cite></span></li><li id="cite_note-Wolf-34"> <span id="mw-reference-text-cite_note-Wolf-34" class="mw-reference-text"><cite id="CITEREFWolf_JEShander_DHuber_FJackson_J2007" class="citation journal cs1">Wolf JE; Shander D; Huber F; Jackson J; Lin CS; Mathes BM; Schrode K; the Eflornithine Study Group. (January 2007). "Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCI 13.9% cream in the treatment of women with facial hair". <i>Int J Dermatol</i>. <b>46</b> (1): 94â8. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x'" tppabs="https://doi.org/10.1111%2Fj.1365-4632.2006.03079.x" class="external text external">10.1111/j.1365-4632.2006.03079.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17214730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17214730'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17214730" class="external text external">17214730</a>.</cite></span></li><li id="cite_note-Pepin_J,_Milord_F,_Guern_C,_Schechter_PJ_1987._1431â3-35"> <span id="mw-reference-text-cite_note-Pepin_J,_Milord_F,_Guern_C,_Schechter_PJ_1987._1431â3-35" class="mw-reference-text"><cite id="CITEREFPepinMilordGuernSchechter1987" class="citation journal cs1">Pepin J, Milord F, Guern C, Schechter PJ (1987). "Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness". <i>Lancet</i>. <b>2</b> (8573): 1431â3. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2887%2991131-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2887%2991131-7'" tppabs="https://doi.org/10.1016%2FS0140-6736%2887%2991131-7" class="external text external">10.1016/S0140-6736(87)91131-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2891995  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2891995'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2891995" class="external text external">2891995</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/tdrold/publications/tdrnews/news64/eflornithine.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/tdrold/publications/tdrnews/news64/eflornithine.htm'" tppabs="http://www.who.int/tdrold/publications/tdrnews/news64/eflornithine.htm" class="external text external">"New lease of life for resurrection drug"</a>.</cite></span></li><li id="cite_note-MSF-37"> <span id="mw-reference-text-cite_note-MSF-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed'" tppabs="http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed" class="external text external">"Supply of sleeping sickness drugs confirmed"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20150921203626/http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150921203626/http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed'" tppabs="https://web.archive.org/web/20150921203626/http://www.msf.org/article/supply-sleeping-sickness-drugs-confirmed" class="external text external">Archived</a> from the original on 2015-09-21.</cite></span></li><li id="cite_note-en.sanofi-aventis.com-38"> <span id="mw-reference-text-cite_note-en.sanofi-aventis.com-38" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf'" tppabs="http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf" class="external text external">"Sanofi-Aventis Access to Medicines Brochure"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20081114211421/http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081114211421/http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf'" tppabs="https://web.archive.org/web/20081114211421/http://en.sanofi-aventis.com/binaries/brochure_aam_en_tcm28-18133.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2008-11-14.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20060829033157/http://www.ifpma.org/Health/other_infect/health_sleep.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060829033157/http://www.ifpma.org/Health/other_infect/health_sleep.aspx'" tppabs="https://web.archive.org/web/20060829033157/http://www.ifpma.org/Health/other_infect/health_sleep.aspx" class="external text external">"IFPMA Health Initiatives: Sleeping Sickness"</a>. Archived from <a href="javascript:if(confirm('http://www.ifpma.org/Health/other_infect/health_sleep.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ifpma.org/Health/other_infect/health_sleep.aspx'" tppabs="http://www.ifpma.org/Health/other_infect/health_sleep.aspx" class="external text external">the original</a> on 2006-08-29.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://drugs-about.com/drugs-o/ornidyl.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://drugs-about.com/drugs-o/ornidyl.html'" tppabs="http://drugs-about.com/drugs-o/ornidyl.html" class="external text external">"Ornidyl facts"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20110720160205/http://drugs-about.com/drugs-o/ornidyl.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110720160205/http://drugs-about.com/drugs-o/ornidyl.html'" tppabs="https://web.archive.org/web/20110720160205/http://drugs-about.com/drugs-o/ornidyl.html" class="external text external">Archived</a> from the original on 2011-07-20.</cite></span></li><li id="cite_note-Vaniqa_Training_Programme_Module_5-41"> <span id="mw-reference-text-cite_note-Vaniqa_Training_Programme_Module_5-41" class="mw-reference-text"><cite class="citation journal cs1">"Vaniqa Training Programme Module 5".</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails'" tppabs="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>. <i>www.accessdata.fda.gov</i>. <a href="javascript:if(confirm('https://www.webcitation.org/6SN0rqosx?url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.webcitation.org/6SN0rqosx?url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails'" tppabs="https://www.webcitation.org/6SN0rqosx?url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails" class="external text external">Archived</a> from the original on 2014-09-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-17</span></span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://web.archive.org/web/20140506075619/http://www.biomedcentral.com/content/pdf/1756-3305-3-15.pdf/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140506075619/http://www.biomedcentral.com/content/pdf/1756-3305-3-15.pdf/'" tppabs="https://web.archive.org/web/20140506075619/http://www.biomedcentral.com/content/pdf/1756-3305-3-15.pdf/" class="external text external">History of Drug Development for African Sleeping Sickness</a></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Other_dermatological_preparations_(D11)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Other_dermatological_preparations_(D11)" style="font-size:114%;margin:0 4em">Other dermatological preparations (D11)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-seborrheics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><i>Antifungals</i>
<ul><li><a href="Bifonazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Bifonazole" title="Bifonazole">Bifonazole</a></li>
<li>Cetrimonium bromide (cetrimide)</li>
<li>Ciclopirox olamine (ciclopirox)</li>
<li>Climbazole</li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Miconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Miconazole" title="Miconazole">Miconazole</a></li>
<li>Piroctone olamine</li>
<li><a href="Selenium_disulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Selenium_disulfide" title="Selenium disulfide">Selenium disulfide (selenium sulfide)</a></li>
<li><span class="new">Xenysalate</span></li>
<li><a href="Zinc_pyrithione.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc_pyrithione" title="Zinc pyrithione">Zinc pyrithione (pyrithione zinc)</a></li></ul></li>
<li><i>Antihistamines</i></li>
<li><i>Calcineurin inhibitors</i>
<ul><li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporin" title="Cyclosporin" class="mw-redirect">Cyclosporin</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li><i>Keratolytics</i>
<ul><li>Coal tar</li>
<li><a href="Resorcinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Resorcinol" title="Resorcinol">Resorcinol</a></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylic acid</a></li>
<li><a href="Sulfur.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur" title="Sulfur">Sulfur</a></li>
<li><a href="Urea.htm" tppabs="https://ptable.com/wiki/compounds/A/Urea" title="Urea">Urea</a> (urea-containing cream)</li></ul></li>
<li><i>Lithium salts</i>
<ul><li>Lithium gluconate</li>
<li>Lithium succinate</li></ul></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin lightening</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Hydroquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroquinone" title="Hydroquinone">Hydroquinone</a></li>
<li><a href="Mequinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mequinol" title="Mequinol">Mequinol</a></li>
<li><a href="Monobenzone.htm" tppabs="https://ptable.com/wiki/compounds/A/Monobenzone" title="Monobenzone">Monobenzone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Skin darkening</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Afamelanotide</li>
<li>Melanotan II</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-inflammatories</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxaceprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li>
<li><a href="Gamma-Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Linolenic_acid" title="Gamma-Linolenic acid">Gamolenic acid</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><i>Topical corticosteroids</i> (e.g., hydrocortisone)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alopecia treatments</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5Î±-Reductase inhibitors</i> 
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li>
<li>Saw palmetto extract</li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Topilutamide (fluridil)</li></ul></li>
<li><i>Potassium channel openers</i>
<ul><li><a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">Minoxidil</a></li></ul></li>
<li><i>Others</i>
<ul><li>Nepidermin</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hair growth inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>5Î±-Reductase inhibitors</i>
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul></li>
<li><i>Antiandrogens</i>
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li>
<li><a href="Eflornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eflornithine" title="Eflornithine">Eflornithine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens (e.g., testosterone)</li>
<li><a href="Brimonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brimonidine" title="Brimonidine">Brimonidine</a></li>
<li><a href="Calcium_gluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a></li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>)</li>
<li>Hyaluronic acid</li>
<li><a href="Magnesium_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium_sulfate" title="Magnesium sulfate">Magnesium sulfate</a></li>
<li>Pregnenolone acetate</li>
<li>Progestogens (e.g., progesterone)</li>
<li><a href="Povidone-iodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Povidone-iodine" title="Povidone-iodine">Povidone-iodine</a></li>
<li>Tiratricol</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antiparasitics_â_antiprotozoal_agents_â_Excavata_antiparasitics_(P01)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiparasitics_â_antiprotozoal_agents_â_Excavata_antiparasitics_(P01)" style="font-size:114%;margin:0 4em">Antiparasitics<span>&nbsp;</span>â antiprotozoal agents<span>&nbsp;</span>â Excavata antiparasitics (P01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Discicristata</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Trypanosomiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">African trypanosomiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine">ornithine</a> (<a href="Eflornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eflornithine" title="Eflornithine">Eflornithine</a><sup>#</sup>)</li>
<li>arsenical (Melarsoprol<sup>#</sup>)</li>
<li><a href="Benzamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamidine" title="Benzamidine">benzamidine</a> (<a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">Pentamidine</a><sup>#</sup>)</li>
<li>naphthalenesulfonate (<a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a><sup>#</sup>)<br></li>
<li>nitroimidazole (Fexinidazole<sup>â </sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Chagas disease</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (Benznidazole<sup>#</sup>)</li>
<li>nitrofuran (Nifurtimox<sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Leishmaniasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>macrolide (<a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">Amphotericin B</a><sup>#</sup>)</li></ul>

<p>Pentavalent antimonials (Meglumine antimoniate<sup>#</sup>, <a href="Sodium_stibogluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_stibogluconate" title="Sodium stibogluconate">Sodium stibogluconate</a>)</p>

<ul><li><a href="Benzamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamidine" title="Benzamidine">benzamidine</a> (<a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">Pentamidine</a><sup>#</sup>)</li>
<li>phosphorylcholine (<a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a>)</li>
<li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">neomycin</a> (<a href="Paromomycin_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Paromomycin_sulfate" title="Paromomycin sulfate" class="mw-redirect">Paromomycin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PAM</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>macrolide (<a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">Amphotericin B</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Trichozoa</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Giardiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (<a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a><sup>#</sup>, <a href="Tinidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Tinidazole" title="Tinidazole">Tinidazole</a>)</li>
<li><a href="Benzimidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzimidazole" title="Benzimidazole">benzimidazole</a> (<a href="Albendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Albendazole" title="Albendazole">Albendazole</a>)</li></ul>

<ul><li><span class="new">thiazolide</span> (<a href="Nitazoxanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitazoxanide" title="Nitazoxanide">Nitazoxanide</a>)</li>
<li>nitrofuran (<a href="Furazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazolidone" title="Furazolidone">Furazolidone</a>)</li></ul>

<ul><li><a href="9-Aminoacridine.htm" tppabs="https://ptable.com/wiki/compounds/A/9-Aminoacridine" title="9-Aminoacridine">aminoacridine</a> (<a href="Quinacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinacrine" title="Quinacrine" class="mw-redirect">Quinacrine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Trichomoniasis</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (Carnidazole, <a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a><sup>#</sup>, <a href="Tinidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Tinidazole" title="Tinidazole">Tinidazole</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Dientamoebiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (<a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a></li>
<li>Secnidazole)<br></li></ul>

<ul><li><a href="8-Hydroxyquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxyquinoline" title="Oxyquinoline" class="mw-redirect">oxyquinoline</a> (<a href="Diiodohydroxyquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Diiodohydroxyquinoline" title="Diiodohydroxyquinoline">Iodoquinol</a>)</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">tetracycline</a> (<a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a>)</li>
<li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">neomycin </a> (Paromomycin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>â¡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>â </sup>Phase III</li>
<li><sup>Â§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>









<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-09" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Eflornithine&oldid=972042560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Eflornithine&oldid=972042560'" tppabs="https://en.wikipedia.org/wiki/?title=Eflornithine&oldid=972042560">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>